Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -701.55% is 123% below its 5-year average of -314.24%, near the high end of its 5-year range (-5360.54%–-9.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 59.09% above its 12-month average of -1715.00%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -701.55%.
RETURN ON INVESTED CAPITAL (ROIC)
-701.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-1715.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-499.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-314.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+59.09%
CURRENT VS 3Y AVG
-40.32%
CURRENT VS 5Y AVG
-123.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.98%
median of 700 covered companies
CURRENT VS SECTOR MEDIAN
-1964.29%
vs the sector median at left
Greenwich LifeSciences, Inc.
Market Cap
$243.66M
Return on Invested Capital (ROIC)
-701.55%
TTM Avg
-1715.00%
3Y Avg
-499.97%
5Y Avg
-314.24%
Market Cap
$243.81M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-8.11%
3Y Avg
-7.60%
5Y Avg
-6.24%
Market Cap
$243.34M
Return on Invested Capital (ROIC)
-1718.59%
TTM Avg
-749.70%
3Y Avg
-566.74%
5Y Avg
-409.31%
Market Cap
$244.64M
Return on Invested Capital (ROIC)
-59.90%
TTM Avg
-142.39%
3Y Avg
-118.24%
5Y Avg
-103.50%
Market Cap
$240.31M
Return on Invested Capital (ROIC)
-7.08%
TTM Avg
-12.89%
3Y Avg
-21.42%
5Y Avg
-39.95%
Market Cap
$240.66M
Return on Invested Capital (ROIC)
-69.76%
TTM Avg
-64.00%
3Y Avg
-45.05%
5Y Avg
-31.07%
Market Cap
$246.88M
Return on Invested Capital (ROIC)
-40.52%
TTM Avg
-35.57%
3Y Avg
-28.84%
5Y Avg
-24.57%
Market Cap
$240.09M
Return on Invested Capital (ROIC)
-25.38%
TTM Avg
-99.58%
3Y Avg
-69.59%
5Y Avg
-61.10%
Market Cap
$246.59M
Return on Invested Capital (ROIC)
19.43%
TTM Avg
-27.12%
3Y Avg
-53.95%
5Y Avg
-48.02%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | $243.66M | -701.55% | -1715.00% | -499.97% | -314.24% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.81M | N/A | -8.11% | -7.60% | -6.24% |
| Galectin Therapeutics Inc. (GALT)vs › | $243.34M | -1718.59% | -749.70% | -566.74% | -409.31% |
| Invivyd, Inc. (IVVD)vs › | $244.64M | -59.90% | -142.39% | -118.24% | -103.50% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $240.31M | -7.08% | -12.89% | -21.42% | -39.95% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.66M | -69.76% | -64.00% | -45.05% | -31.07% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $246.88M | -40.52% | -35.57% | -28.84% | -24.57% |
| InflaRx N.V. (IFRX)vs › | $240.09M | -25.38% | -99.58% | -69.59% | -61.10% |
| Q32 Bio Inc. (QTTB)vs › | $246.59M | 19.43% | -27.12% | -53.95% | -48.02% |
| Century Therapeutics, Inc. (IPSC)vs › | $248.98M | -43.69% | -34.60% | -35.16% | -35.84% |
ROIC
-701.6%
ROE
-695.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -701.55% |
| 2026-03-31 | -415.38% |
| 2025-12-31 | -5360.54% |
| 2025-09-30 | -872.94% |
| 2025-06-30 | -1224.59% |
| 2025-03-31 | -1237.77% |
| 2024-12-31 | -631.87% |
| 2024-09-30 | -216.02% |
| 2024-06-30 | -179.35% |
| 2024-03-31 | -187.94% |
| 2023-12-31 | -139.21% |
| 2023-09-30 | -106.03% |
| 2023-06-30 | -87.01% |
| 2023-03-31 | -70.97% |
| 2022-12-31 | -60.85% |
| 2022-09-30 | -48.82% |
| 2022-06-30 | -35.40% |
| 2022-03-31 | -30.68% |
| 2021-12-31 | -17.14% |
| 2021-09-30 | -11.85% |
| 2021-06-30 | -9.47% |
| 2021-03-31 | -7.46% |
| 2020-12-31 | -6.68% |
| 2020-09-30 | -19.81% |
